Author:
Brodie Angela M. H.,Santen Richard J.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. McGuire WL: An update on estrogen and progesterone receptors in prognosis for primary and advanced breast Cancer.In: Iacobelli Set al (eds) Hormones and Cancer, Vol. 15. Raven Press, New York, 1980, pp 337?344.
2. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339:1?15, 1992.
3. Santen RJ, Worgul TJ, Lipton A, Harvey HA, Boucher A, Samojlik E, Wells SA: Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma: correlation of clinical and hormonal responses. Ann Intern Med 96:94?101, 1982.
4. Goss PE, Coombes RL, Powles TJ, Dowsett M, Brodie AMH: Treatment of advanced postmenopausal breast cancer with aromatase inhibitor, 4-hydroxyandrostenedione ? Phase 2 report. Cancer Res 46:4823?4826, 1986.
5. Thompson EA Jr, Siiteri PK: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249:5364?5372, 1974.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献